WELL Stock Analysis: Welltower | NYSE
REIT - Healthcare Facilities | NYSE, USA | Market Cap: 160.758m USD | 12M Return: 59% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 775M
EPS Trend: 88.7%
Qual. Beats: 0
Rev. Trend: 98.5%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Welltower Inc. (NYSE: WELL) is a S&P 500 healthcare REIT that owns and operates a portfolio of 2,000+ senior housing and wellness communities across the United States, United Kingdom, and Canada, primarily serving aging renters through a rental housing model. The company describes itself as an operating company in a real estate wrapper, combining real estate ownership with active property operations supported by a proprietary data science platform and its internal Welltower Business System.
The healthcare REIT subsector in which Welltower operates invests in real estate assets tied to the healthcare services industry, with senior housing operators leasing properties from the REIT under triple-net or RIDEA-style structures. Demographic tailwinds from the aging population in North America and Western Europe are a key structural driver for senior housing REITs. Welltower was incorporated in Delaware in 1970 and is headquartered in Toledo, Ohio.
- Senior housing occupancy and RevPOR growth expand SHOP segment margins
- Higher interest rates compress acquisition spreads and cap rate economics
- Baby boomer demographics fuel long-term senior housing demand growth
| Net Income: 1.41b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.71 > 1.0 |
| NWC/Revenue: 43.73% < 20% (prev 65.28%; Δ -21.55% < -1%) |
| CFO/TA 0.04 > 3% & CFO 2.95b > Net Income 1.41b |
| Net Debt (17.3b) to EBITDA (2.64b): 6.57 < 3 |
| Current Ratio: 3.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (726.3m) vs 12m ago 11.08% < -2% |
| Gross Margin: 38.87% > 18% (prev 38.23%; Δ 0.64% > 0.5%) |
| Asset Turnover: 19.22% > 50% (prev 15.78%; Δ 3.44% > 0%) |
| Interest Coverage Ratio: 0.52 > 6 (EBIT TTM 366.2m / Interest Expense TTM 699.7m) |
| A: 0.08 (Total Current Assets 7.37b - Total Current Liabilities 2.31b) / Total Assets 67.2b |
| B: -0.13 (Retained Earnings -8.96b / Total Assets 67.2b) |
| C: 0.01 (EBIT TTM 366.2m / Avg Total Assets 60.3b) |
| D: 1.96 (Book Value of Equity 43.8b / Total Liabilities 22.3b) |
| Altman-Z'' = 2.16 = BBB |
| DSRI: 0.52 (Receivables 2.55b/3.58b, Revenue 11.6b/8.41b) |
| GMI: 0.98 (GM 38.23% / 38.87%) |
| AQI: 0.10 (AQ_t 0.09 / AQ_t-1 0.84) |
| SGI: 1.38 (Revenue 11.6b / 8.41b) |
| TATA: -0.02 (NI 1.41b - CFO 2.95b) / TA 67.2b) |
| Beneish M = -3.70 (Cap -4..+1) = AAA |
As of July 03, 2026, the stock is trading at USD 236.06 with a total of 4,128,757 shares traded. Over the past week, the price has changed by +5.51%, over one month by +20.84%, over three months by +17.07% and over the past year by +59.04%.
Current recommended Stop Loss: 228.00 (which is 3.4% or 1.4 ATR below the current price).
Welltower has received a consensus analysts rating of 4.30. Therefore, it is recommended to buy WELL.
- StrongBuy: 10
- Buy: 6
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 235.5 | -0.2% |
P/E Trailing = 110.0145
P/E Forward = 77.5194
P/S = 13.6619
P/B = 3.6644
P/EG = 3.6218
Revenue TTM = 11.6b USD
EBIT TTM = 366.2m USD
EBITDA TTM = 2.64b USD
Long Term Debt = 17.9b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 22.0b USD (from shortLongTermDebtTotal, last quarter) + Leases 2.05b
Net Debt = 17.3b USD (calculated: Debt 22.0b - CCE 4.70b)
Enterprise Value = 178b USD (161b + Debt 22.0b - CCE 4.70b)
Interest Coverage Ratio = 0.52 (Ebit TTM 366.2m / Interest Expense TTM 699.7m)
EV/FCF = 70.06x (Enterprise Value 178b / FCF TTM 2.54b)
FCF Yield = 1.43% (FCF TTM 2.54b / Enterprise Value 178b)
FCF Margin = 21.94% (FCF TTM 2.54b / Revenue TTM 11.6b)
Net Margin = 12.15% (Net Income TTM 1.41b / Revenue TTM 11.6b)
Gross Margin = 38.87% ((Revenue TTM 11.6b - Cost of Revenue TTM 7.08b) / Revenue TTM)
Gross Margin QoQ = 37.82% (prev 38.30%)
Tobins Q-Ratio = 2.65 (Enterprise Value 178b / Total Assets 67.2b)
Interest Expense / Debt = 3.18% (Interest Expense 699.7m / Debt 22.0b)
Taxrate = 0.68% (10.0m / 1.47b)
NOPAT = 363.7m (EBIT 366.2m * (1 - 0.68%))
Current Ratio = 3.20 (Total Current Assets 7.37b / Total Current Liabilities 2.31b)
Debt / Equity = 0.50 (Debt 22.0b / totalStockholderEquity, last quarter 43.8b)
Debt / EBITDA = 6.57 (Net Debt 17.3b / EBITDA 2.64b)
Debt / FCF = 6.82 (Net Debt 17.3b / FCF TTM 2.54b)
Total Stockholder Equity = 40.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.34% (Net Income 1.41b / Total Assets 67.2b)
RoE = 3.51% (Net Income TTM 1.41b / Total Stockholder Equity 40.1b)
RoCE = 0.63% (EBIT 366.2m / Capital Employed (Equity 40.1b + L.T.Debt 17.9b))
RoIC = 0.57% (NOPAT 363.7m / Invested Capital 64.3b)
WACC = 5.39% (E(161b)/V(183b) * Re(5.70%) + D(22.0b)/V(183b) * Rd(3.18%) * (1-Tc(0.01)))
Discount Rate = 5.70% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 100.00 | Cagr: 12.93%
[DCF] Terminal Value 76.23% ; FCFF base≈2.48b ; Y1≈2.62b ; Y5≈3.07b
[DCF] Fair Price = 42.43 (EV 47.3b - Net Debt 17.3b = Equity 30.0b / Shares 705.9m; r=8.35% [WACC [floored]]; 5y FCF grow 6.24% → 2.50% )
EPS Correlation: 88.72 | EPS CAGR: 96.03% | SUE: 0.33 | # QB: 0
Revenue Correlation: 98.48 | Revenue CAGR: 26.52% | SUE: 1.37 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.67 | Chg30d=-5.00% | Revisions=N/A | Analysts=2
EPS current Year (2026-12-31): EPS=3.01 | Chg30d=+0.00% | Revisions=N/A | GrowthEPS=+117.2% | GrowthRev=+30.0%
EPS next Year (2027-12-31): EPS=3.36 | Chg30d=+0.00% | Revisions=-20% | GrowthEPS=+11.6% | GrowthRev=+13.3%
[Analyst] Revisions Ratio: -20%